Elidel and Lymph follicular hypertrophy - a phase IV clinical study of FDA data
Lymph follicular hypertrophy is found among people who take Elidel, especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Elidel and have Lymph follicular hypertrophy. It is created by eHealthMe based on reports of 4,137 people who have side effects when taking Elidel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
4,137 people reported to have side effects when taking Elidel.
Among them, 240 people (5.8%) have Lymph follicular hypertrophy.
What is Elidel?
Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 4,190 Elidel users for its effectiveness, alternative drugs and more.
What is Lymph follicular hypertrophy?
Lymph follicular hypertrophy (an increase in the size of the lymph node follicles) is found to be associated with 2,379 drugs and 1,860 conditions by eHealthMe.
Number of Elidel and Lymph follicular hypertrophy reports submitted per year:
Time on Elidel when people have Lymph follicular hypertrophy *:
Gender of people who have Lymph follicular hypertrophy when taking Elidel*:
Age of people who have Lymph follicular hypertrophy when taking Elidel *:
Common drugs people take besides Elidel *:
Common side effects people have besides Lymph follicular hypertrophy *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Elidel and have Lymph follicular hypertrophy?Check whether Lymph follicular hypertrophy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Elidel:
- Elidel (4,190 reports)
Lymph follicular hypertrophy treatments and more:
- Lymph follicular hypertrophy (38,270 reports)
COVID vaccines that are related to Lymph follicular hypertrophy:
- Lymph follicular hypertrophy in Moderna COVID Vaccine
- Lymph follicular hypertrophy in Pfizer BioNTech Covid Vaccine
- Lymph follicular hypertrophy in Johnson and Johnson Covid Vaccine
How severe was Lymph follicular hypertrophy and when was it recovered:
Expand to all the drugs that have ingredients of pimecrolimus:
Common drugs associated with Lymph follicular hypertrophy:
All the drugs that are associated with Lymph follicular hypertrophy:
- Lymph follicular hypertrophy (2,379 drugs)
Common conditions associated with Lymph follicular hypertrophy:
All the conditions that are associated with Lymph follicular hypertrophy:
- Lymph follicular hypertrophy (1,860 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pimecrolimus (the active ingredients of Elidel) and Elidel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gilenya and Breast Infection - a second ago
- Augmentin and Acetaminophen drug interaction - 2 seconds ago
- Perforomist and Gastritis - 23 seconds ago
- Tetracycline Hydrochloride and Vitamin B12 drug interaction - 25 seconds ago
- Amiloride Hydrochloride vs. Potassium Chloride - 26 seconds ago